<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0309234089
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RIALOCAINE 2 % Gel
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        LIDOCAINE HYDROCHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Gel
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tube
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        11
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D04AB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        C05AD01
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>RIALOCAINE GEL is used to produce a temporary loss of feeling or numbness of the skin in adults and children 2 years of age and older, and can be used</p><ul><li>before certain types of examinations done by your doctor</li><li>to help relieve the pain from inflammation of the urinary bladder and the urethra</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use RIALOCAINE GEL</strong></p><p>If you are allergic to Lidocaine Hydrochloride (active substance) or to any of the ingredients of RIALOCAINE GEL</p><p><strong>Take special care with RIALOCAINE GEL</strong></p><p><strong>Before using RIALOCAINE GEL: </strong>Tell your doctor or pharmacist</p><ul><li>about all health problems you have now or have had in the past</li><li>about other medicines you take, including ones you can buy without a prescription</li><li>if you are taking other medicines such as drugs used to treat irregular heart activity (anti-arrhythmics</li><li>if you have ever had a bad, unusual or allergic reaction to RIALOCAINE GEL or any other medicines ending with &ldquo;caine</li><li>if you think you may be allergic or sensitive to any ingredients in RIALOCAINE GEL if there is an infection, skin rash, cut or wound at or near the area you want to apply RIALOCAINE GEL</li><li>if you have a skin condition that is severe or that covers a large area</li><li>if you have a severe heart, kidney or liver disease</li><li>if you have epilepsy (there is very low risk if used as per proper use</li><li>If you or someone in your family has been diagnosed with porphyria</li><li>if you are experiencing severe shock</li><li>if you are pregnant, plan to become pregnant or are breastfeeding</li></ul><p><strong>Other medicines and RIALOCAINE GEL </strong></p><p>Tell your doctor or pharmacist about any other drugs you<strong> </strong>take, including</p><ul><li>drugs you can buy without a prescription</li><li>anti-arrhythmic drugs for heart problems (e.g. mexiletine, amiodarone</li><li>other anesthetics</li><li>propranolol for heart problems or cimetidine for gastrointestinal problems, if you are going to use high doses of RIALOCAINE GEL for a long time</li><li>fluvoxamine, for depression, if you are going to use high doses of RIALOCAINE GEL for a long time</li></ul><p>Please inform your doctor/dentist/pharmacist if you are taking or have recently taken any other medicines, even those that can be bought without a prescription. Usage of such medicines at the same time may increase the risk of serious side effects</p><p><strong>Pregnancy and breast-feeding</strong></p><p>It is not known if RIALOCAINE GEL can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Lidocaine gel while you are pregnant. It is not known if Lidocaine gel is found in breast milk after topical use. If you are or will be breast-feeding while you use RIALOCAINE GEL, check with your doctor. Discuss any possible risks to your baby</p><p><strong>Driving and using machines</strong></p><p>No or negligible influence</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always use RIALOCAINE GEL exactly as your doctor or pharmacist has told you</strong></p><p><strong>Check with your doctor or pharmacist if you are not sure</strong></p><p><strong>Usual Dose</strong></p><p>If this medicine is recommended by your doctor, be sure to follow the directions for use that have been given. If you are treating yourself, such as for the treatment of pain caused by inflammation of the urethra or urinary bladder, or for self catheterization, follow the directions below and your doctor&rsquo;s or pharmacist&rsquo;s instructions for how to apply the gel. Check with your doctor or pharmacist if you have any questions about your directions</p><p>The following are general guidelines for the maximum amount of Rialocaine gel that should be used without a doctor&rsquo;s advice. These guidelines apply only to otherwise healthy people. If you have a special skin or other condition that requires a doctor&rsquo;s supervision ask your doctor about the maximum amount of jelly that you should use</p><p>(Do not use more Rialocaine gel more often or for a longer period of time than either your doctor ordered or than these package directions suggest as this may cause unwanted side effects (see Possible side effects</p><ul><li>If possible, clean the affected area well, before each application of gel</li><li>Use the smallest amount of gel needed to control your symptoms</li><li>Avoid contact with your eyes</li></ul><p><strong>Conditions where dose adjustments may be required</strong></p><ul><li>elderly patients</li><li>acutely ill patients</li><li>patients with severe liver disease</li><li>patients with severe kidney disease</li><li>patients also treated with other anesthetics or certain antiarrhythmic drugs (such as amiodarone or mexiletine</li></ul><p><strong>Dose for Adults</strong></p><p>The dose of the gel depends on the application site. For use in the urethra (i.e., before insertion of urinary catheters or urinary procedures), 5 to 20 ml (100-400 mg Lidocaine Hydrochloride) is usually enough. A safe dose for use in the urethra and bladder is 40 ml (800mg Lidocaine Hydrochloride)</p><p>No more than four doses should be given during a 24-hour period</p><p><strong>Dose for Children Under 12 Years of Age:</strong></p><p>The dose depends on the child&rsquo;s weight. No more than 3 ml (60mg Lidocaine Hydrochloride) of gel per 10 kilograms of the child&rsquo;s weight should be used per dose. For a 10 kg child the dose should be no more than 3 ml (60mg Lidocaine Hydrochloride). No more than four doses should be given during a 24-hour period</p><ul><li>For use in children under 2 years of age, consult a doctor</li><li>If you have any questions about how to measure the above amounts, be sure to ask your pharmacist</li><li>If you are treating yourself and your condition does not seem to improve within three to five days, check with your doctor about continuing to use RIALOCAINE GEL</li></ul><p><strong>If you use more RIALOCAINE GEL than you should</strong></p><p>Early signs of overdosage are numbness of the lips and around the mouth, lightheadedness, dizziness and sometimes blurred vision. In the event of a serious overdosage, trembling, seizures or unconsciousness may occur</p><p>If the early signs of overdosage are noticed and no further RIALOCAINE GEL is given, the risk of serious adverse effects occurring rapidly decreases. If you think you or anyone else is experiencing any of the above signs, telephone your doctor or go to the nearest hospital right away</p><p><strong>If you forget to use RIALOCAINE GEL</strong></p><p>If you miss a dose of RIALOCAINE GEL, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule</p><p><strong>If you have any further questions on the use of this</strong> <strong>medicine, ask your doctor or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, RIALOCAINE GEL can cause side effects, although not everybody gets them</p><ul><li>Avoid eating or chewing gum when RIALOCAINE GEL is used in the mouth or throat since numbness in these areas may interfere with swallowing and could potentially cause choking. Numbness of the tongue or gums may also increase the danger of injury due to biting</li><li>Avoid exposure to extreme hot or cold temperatures (e.g. food, drink) until complete sensation has returned</li><li>Avoid contact with the eyes because numbness in the eyes may prevent you from noticing if you get something in your eye</li></ul><p>With the recommended doses, RIALOCAINE GEL has no effect on the ability to drive and use machines</p><p><strong>Serious side effects, how often they happen and what to do about them</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:700px"><thead><tr><td colspan="4">&nbsp;</td></tr><tr><td><p><strong>Symptom / effect</strong></p></td><td><p><strong>Talk with your doctor, nurse, or pharmacist&nbsp;<em>only if severe</em></strong></p></td><td><p><strong>Talk with your doctor, nurse, or pharmacist&nbsp;<em>in all cases</em></strong></p></td><td><p><strong>Stop taking drug and talk with your doctor or pharmacist</strong></p></td></tr></thead><tbody><tr><td colspan="4"><p><strong>Rare (frequency greater than or equal to 0.01% but less than 0.1% of patients)</strong></p></td></tr><tr><td><p><strong>Allergic reaction such as:</strong>&nbsp;redness, itching or swelling of your skin, hives, burning, stinging, or any other skin problems, swelling of the neck area, or any difficulty with breathing, not present before using this medicine.</p></td><td><p>✔</p></td><td><p>&nbsp;</p></td><td><p>✔</p></td></tr></tbody></table><p><strong><em>This is not a complete list of side effects. For any unexpected effects while taking RIALOCAINE GEL contact your doctor or pharmacist</em></strong></p><p>RIALOCAINE GEL can cause serious side effects if too much is applied. These include: drowsiness, numbness of your tongue, light-headedness, ringing in your ears, blurred vision, vomiting, dizziness, unusually slow heart beat, fainting, nervousness, unusual sweating, trembling or seizures</p><p>The above side effects are extremely rare, but can occur when too much RIALOCAINE GEL is used at one time and when large amounts are used over a long period of time</p><p>Consult your doctor immediately if any of these symptoms appear</p><p><strong>If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of the reach and sight of children</p><p>- Store in original package in order to protect from light</p><p>- Store below 30&deg;C</p><p>- Once the pack has been opened, the contents should be used within one month</p><p>- Do not use RIALOCAINE GEL after the expiry date printed on the pack The expiry date refers to the last day of that month</p><p>- Do not throw any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Sterile Gel</strong></p><p>Each 1 gram contains Lidocaine Hydrochloride (BP) equivalent to anhydrous Lidocaine Hydrochloride 20 mg</p><p>RIALOCAINE GEL also contains: Hypromellose, Glycerol, Methyl Hydroxybenzoate, Propyl Hydroxybenzoate and Water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Rialocaine is homogenous, clear, colorless gel, free from foreign particles
Pack: 20 g or 30 g Aluminium tube with plastic screw cap

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p><em>For any information about this medicinal product, please contact the local representative of marketing authorization holder:</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                1/2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يستخدم ريالوكين جل لعمل فقدان مؤقت للشعور أو خدر للجلد في البالغين والأطفال سنتان وأكبر وكبار السن، ويمكن استخدامها:</p><ul><li>قبل بعض أنواع الفحوصات التي يقوم بها طبيبك.</li><li>للمساعدة في تخفيف الألم من التهاب المثانة البولية والإحليل.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا&nbsp;</strong><strong>تستخدم</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong></p><p>إذا كنت تعاني من حساسية ليدوكين (المادة الفعالة) أو إلى أي من مكونات ريالوكين جل.</p><p><strong>عناية</strong><strong> </strong><strong>خاصة</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong></p><p><strong>قبل</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong><strong>: </strong>أخبر طبيبك أو الصيدلي:</p><ul><li>عن كل المشاكل الصحية التي لديك الآن أو كانت لديك في &nbsp;الماضي ؛</li><li>عن الأدوية الأخرى التي تتناولها، بما في ذلك الأدوية التي يمكنك شراؤها بدون وصفة طبية؛</li><li>إذا كنت تتناول أدوية أخرى مثل الأدوية المستخدمة في علاج نشاط القلب غير المنتظم ( مضادات عدم انتظام ضربات القلب).</li><li>إذا كان لديك في أي وقت مضى حساسية سيئة، غير عادية أو حساسية تجاه ريالوكين جل أو أي أدوية أخرى تنتهي ب &ldquo;كين&rdquo;؛</li><li>إذا كنت تعتقد أنك قد تتطور لديك حساسية أو حساس لأي من المكونات في ريالوكين جل؛</li><li>إذا كان هناك عدوى، طفح جلدي، قطع أو جرح في أو بالقرب من المنطقة التي تريد دهان ريالوكين جل عليها؛</li><li>إذا كان لديك حالة جلدية شديدة أو تغطي مساحة كبيرة؛</li><li>إذا كنت تعاني من أمراض قلبية أو كلى أو كبدية؛</li><li>إذا كان لديك الصرع (هناك خطر منخفض جدا إذا ما استخدمت حسب الاستخدام السليم)؛</li><li>إذا تم تشخيصك أو شخص ما في عائلتك بالبورفيريا؛</li><li>إذا كنت تعاني من صدمة شديدة؛</li><li>إذا کنتي حاملا، تحاولي أن تصبحي حاملا أو مرضعة.</li></ul><p><strong>الأدوية</strong><strong> </strong><strong>الأخرى</strong><strong> </strong><strong>و</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong></p><p>أخبر طبيبك أو الصيدلي عن أي أدوية أخرى تتناولها، بما في ذلك:</p><ul><li>الأدوية التي يمكنك شراؤها دون وصفة طبية.</li><li>الأدوية المضادة لعدم انتظام ضربات القلب لمشاكل في القلب (على سبيل المثال ميكسيليتين، الأميودارون).</li><li>أدوية التخدير الأخرى.</li><li>بروبرانولول لمشاكل القلب أو سيميتيدين لمشاكل الجهاز الهضمي، إذا كنت تنوي استخدام جرعات عالية من ريالوكين جل لفترة طو يلة .</li><li>فلوفوكسامين، للاكتئاب، إذا كنت تنوي استخدام جرعات عالية من ريالوكين جل لفترة طويلة.</li></ul><p>يرجى إبلاغ الطبيب / طبيب الأسنان / الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، حتى تلك التي يمكن شراؤها دون وصفة طبية. استخدام هذه الأدوية في نفس الوقت قد يزيد من خطر الآثار الجانبية الخطيرة.</p><p><strong>الحمل</strong><strong> </strong><strong>والرضاعة</strong><strong> </strong><strong>الطبيعية</strong></p><p>من غير المعروف ما إذا كان ريالوكين جل يمكن أن يسبب ضررا للجنين. إذا أصبحتي حاملا، اتصلي بطبيبك. ستحتاجين لمناقشة فوائد ومخاطر استخدام ريالوكين جل وأنتي حامل. ومن غير المعروف ما إذا تم العثور على ليدوكين في حليب الثدي بعد الاستخدام الموضعي.</p><p>إذا كنتي تُرضعين أو ستستخدمين الرضاعة الطبيعية أثناء استخدام ريالوكين، يرجى مراجعة الطبيب لمناقشة أي مخاطر محتملة لطفلك.</p><p><strong>القيادة</strong><strong> </strong><strong>و</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>الآلات </strong></p><p>لا يوجد تأثير أو تأثير ضئيل.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>دائما</strong><strong> </strong><strong>استخدم</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong><strong> </strong><strong>تماما</strong><strong> </strong><strong>كتوجيهات</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p><p><strong>استشر</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong> </strong><strong>إذا</strong><strong> </strong><strong>لم</strong><strong> </strong><strong>تكن</strong><strong> </strong><strong>متأكدا</strong><strong>.</strong></p><p><strong>الجرعة</strong><strong> </strong><strong>المعتادة</strong></p><p>إذا كان هذا الدواء يوصى به طبيبك، فتأكد من اتباع إرشادات الاستخدام التي أعطيت لك. إذا كنت تعالج نفسك، مثل علاج الألم الناجم عن التهاب مجرى البول أو المثانة البولية، أو للقسطرة الذاتية، اتبع الإرشادات أدناه وتعليمات الطبيب أو الصيدلي لكيفية دهان الجل. تحقق مع طبيبك أو الصيدلي إذا كان لديك أي أسئلة حول ارشادات الاستعمال.</p><p>وفيما يلي إرشادات عامة لأقصى قدر من جل ريالوكين الذي ينبغي استخدامه دون نصيحة الطبيب. تنطبق هذه الإرشادات فقط على الأشخاص الأصحاء. إذا كان لديك بشرة خاصة أو حالة أخرى تتطلب إشراف طبيب اسأل طبيبك عن الحد الأقصى من الجل الذي يجب استخدامه.</p><p>لا تستخدم المزيد من جل ريالوكايين في كثير من الأحيان أو لفترة أطول من الوقت الذي أمر به الطبيب أو مقترح ارشادات الاستعمال حيث أن هذا قد يسبب آثار جانبية غير مرغوب فيها (انظر الآثار الجانبية المحتملة)</p><ul><li>إذا أمكن، قم بتنظيف المنطقة المصابة جيدا قبل كل دهان للجل.</li><li>استخدم أصغر كمية من الجل اللازمة للسيطرة على الأعراض.</li><li>تجنب ملامسة عينيك.</li></ul><p><strong>الحالات</strong><strong> </strong><strong>التي</strong><strong> </strong><strong>قد</strong><strong> </strong><strong>تتطلب</strong><strong> </strong><strong>تعديلات</strong><strong> </strong><strong>الجرعة</strong><strong>:</strong></p><ul><li>المرضى المسنين.</li><li>المرضى الذين يعانون من مرض حاد.</li><li>المرضى الذين يعانون من أمراض الكبد الحاد.</li><li>المرضى الذين يعانون من مرض الكلى الحاد.</li><li>المرضى الذين يعالجون أيضا مع أدوية التخدير الأخرى أو بعض الأدوية المضادة لعدم انتظام ضربات القلب (&nbsp;مثل الأميودارون أو مكسيليتين).</li></ul><p><strong>جرعة</strong><strong> </strong><strong>للبالغين</strong><strong>:</strong></p><p>الجرعة من الجل تعتمد على مكان الاستعمال. للاستخدام في مجرى البول )أي قبل إدخال القسطرة البولية أو جراحات المسالك البولية(، 5 الى 20 مل (100-400 ملجم ليدوكين هيدروكلورايد( عادة ما تكفي الجرعة الآمنة للاستخدام في مجرى البول والمثانة هي 40 مل (٨٠٠ ملجم ليدوكين هيدروكلورايد)</p><p>لا ينبغي إعطاء أكثر من أربع جرعات خلال فترة 24 ساعة.</p><p><strong>جرعة</strong><strong> </strong><strong>الأطفال</strong><strong> </strong><strong>دون</strong><strong> </strong><strong>سن</strong><strong> 12 </strong><strong>سنة</strong><strong> </strong><strong>من</strong><strong> </strong><strong>العمر</strong><strong>:</strong></p><p>الجرعة تعتمد على وزن الطفل. لا ينبغي استخدام أكثر من 3 مل &nbsp;( 60 ملجم ليدوكين هيدروكلورايد) من الجل لكل 10 كجم من وزن الطفل لكل جرعة.</p><p>لطفل 10 كجم الجرعة يجب أن لا تزيد عن 3 مل ( ٦٠ ملجم ليدوكين هيدروكلورايد)</p><p>لا ينبغي إعطاء أكثر من أربع جرعات خلال فترة 24 ساعة.</p><ul><li>للاستعمال في الأطفال دون سن الثانية، استشر الطبيب.</li><li>إذا کان لدیك أي أسئلة حول کیفیة قیاس الجرعات المذکورة أعلاه، تأکد من أن تستشير الصیدلي.</li><li>إذا كنت تعالج نفسك وحالتك لا يبدو أنها تتحسن في غضون ثلاثة إلى خمسة أيام، استشر طبيبك حول الاستمرار في استخدام ريالوكين جل.</li></ul><p><strong>إذا</strong><strong> </strong><strong>استخدمت</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong><strong> </strong><strong>أكثر</strong><strong> </strong><strong>مما</strong><strong> </strong><strong>يجب</strong></p><p>العلامات المبكرة للجرعة الزائدة هي خدر في الشفاه وحول الفم، والدوار، والدوخة وأحيانا عدم وضوح الرؤية. في حالة الجرعة الزائدة الخطيرة، قد يحدث ارتعاش أو نوبات أو فقدان للوعي.</p><p>إذا لاحظت علامات مبكرة للجرعة الزائدة ولم يتم إعطاء المزيد من ريالوكين، فإن خطر الآثار السلبية الخطيرة التي تحدث سوف تنخفض بسرعة. إذا كنت تعتقد أنك أو أي شخص آخر تعاني من أي من العلامات المذكورة أعلاه، اتصل بطبيبك أو انتقل إلى أقرب مستشفى على الفور.</p><p><strong>إذا</strong><strong> </strong><strong>نسيت</strong><strong> </strong><strong>جرعة</strong><strong> </strong><strong>من</strong><strong> </strong><strong>ريالوكين</strong><strong> </strong><strong>جل</strong></p><p>استخدم الجل في أقرب وقت ممكن. إذا حان الوقت تقريبا للجرعة التالية، تخط الجرعة الفائتة، والعودة الى الجدول الزمني الخاص بالجرعات العادية.</p><p><strong>إذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>أسئلة</strong><strong> </strong><strong>أخرى</strong><strong> </strong><strong>عن</strong><strong> </strong><strong>استخدام</strong><strong> </strong><strong>هذا</strong><strong> </strong><strong>الدواء،</strong><strong> </strong><strong>إسأل</strong><strong> </strong><strong>طبيبك أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن ريالوكين جل ان يتسبب في آثار جانبية، على الرغم من أن الجميع لا يحدث لهم.</p><ul><li>تجنب الأكل أو مضغ العلكة عند استخدام ريالوكين جل في الفم أو الحلق حيث أن الخدر في هذه المناطق قد يتداخل مع البلع ويمكن أن يسبب الاختناق. خدر اللسان أو اللثة قد يزيد من خطر الإصابة بسبب العض.</li><li>تجنب التعرض لدرجات حرارة حارة أو باردة شديدة &nbsp;(مثل الطعام والشراب)&nbsp; حتى يعود كامل الإحساس.</li><li>تجنب ملامسة العينين لأن الخدر في العينين قد يمنعك من ملاحظة حدوث أي شيء في عينيك.</li></ul><p>&nbsp;مع الجرعات الموصى بها، ريالوكاين جل ليس له تأثير على القدرة على القيادة واستخدام الآلات</p><p><strong>الآثار الجانبية الخطيرة، ومدى حدوثها وما يجب القيام به حيالها.</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>الأعراض / التأثير</p></td><td style="vertical-align:top"><p>تحدث مع طبيبك ، ممرضك أو الصيدلي فقط إذا كانت الأثار شديدة</p></td><td style="vertical-align:top"><p>تحدث مع طبيبك، ممرضك، أو الصيدلي في جميع الحالات</p></td><td style="vertical-align:top"><p>توقف عن تناول الدواء و تحدث مع طبيبك أو الصيدلي</p></td></tr><tr><td colspan="4" style="vertical-align:top"><p>نادر (التكرار أكبر من أو يساوي 0.01٪ ولكن أقل من 0.1٪ من المرضى)</p></td></tr><tr><td style="vertical-align:top"><p>رد فعل تحسسي مثل: احمرار أو حكة أو تورم في الجلد أو حساسية شديدة أو الحرق أو اللدغة أو أي مشاكل جلدية أخرى أو تورم في منطقة الرقبة أو أي صعوبة في التنفس مع عدم وجودها قبل استخدام هذا الدواء</p></td><td><p>✔</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td><p>✔</p></td></tr></tbody></table><p><strong>هذه</strong><strong> </strong><strong>ليست</strong><strong> </strong><strong>قائمة</strong><strong> </strong><strong>كاملة</strong><strong> </strong><strong>للأثار</strong><strong> </strong><strong>الجانبية</strong><strong>. </strong><strong>عن</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>متوقعة أثناء</strong><strong> </strong><strong>استعمال</strong><strong> </strong><strong>ريالوكاين</strong><strong> </strong><strong>جل</strong><strong> </strong><strong>اتصل</strong><strong> </strong><strong>بالطبيب أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong></p><p>ريالوكين جل يمكن أن يسبب آثار جانبية خطيرة إذا تم استخدام الكثير منه. وتشمل هذه: النعاس، وخدر اللسان، ورأس خفيفة، ورنين في أذنيك، وعدم وضوح الرؤية، والتقيؤ، والدوخة، وبطء غير عادي في ضربات القلب، والإغماء، والعصبية، وتعرق غير عادي، الارتجاف أو النوبات.</p><p>الآثار الجانبية المذكورة أعاه نادرة للغاية، ولكن يمكن أن يحدث عندما يتم استخدام الكثير من ريالوكين مرة واحدة، وعندما يتم استخدام كميات كبيرة على مدى فترة طويلة من الزمن. استشر طبيبك فورا إذا ظهرت أي من هذه الأعراض.</p><p><strong>اذا</strong><strong> </strong><strong>كان</strong><strong> </strong><strong>لديك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية،</strong><strong> </strong><strong>قم</strong><strong> </strong><strong>بالتحدث</strong><strong> </strong><strong>مع</strong><strong> </strong><strong>طبيبك</strong><strong> </strong><strong>أو</strong><strong> </strong><strong>الصيدلي</strong><strong>.</strong><strong> ويشمل</strong><strong> </strong><strong>ذلك</strong><strong> </strong><strong>أي</strong><strong> </strong><strong>آثار</strong><strong> </strong><strong>جانبية</strong><strong> </strong><strong>غير</strong><strong> </strong><strong>المذكورة</strong><strong> </strong><strong>في</strong><strong> </strong><strong>هذه</strong><strong> </strong><strong>النشرة.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</p><p>- يحفظ في العبوة الأصلية للحماية من الضوء.</p><p>- يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p>- بمجرد فتح العبوة يجب استخدام المستحضر خلال شهر واحد.</p><p>- يجب عدم الاستعمال بعد تاريخ انتهاء الصلاحية المذكور على العبوة.</p><p>- التخلص من الأدوية يجب ألا يكون عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير تساعد في حماية البيئة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي كل 1 جرام على ليدوكين هيدروكلورايد (دستور الأدوية البريطاني) ما يعادل ليدوكين هيدروكلورايد لا مائي 20 ملجم. يحتوي ريالوكين جل أيضاً على: هيبروميللوز، جليسيرول، ميثيل هيدروكسي بنزوات، بروبيل هيدروكسي بنزوات وماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ريالوكيين عبارة عن جل متجانس، شفاف، عديم اللون، خالي من الشوائب. العبوة: 20 جم أو 30 جم في أنبوب من الألومنيوم مع غطاء بلا ستيكي .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة المنتجات الطبية والتجميلية المحدودة (الرياض فارما(</p><p>ص.ب. 442 الرياض 11411</p><p>فاكس : 966112650505+&nbsp; &nbsp;</p><p>البريد الإلكتروني : contact@riyadhpharma.com</p><p>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</p><p>المملكة العربية السعودية</p><p>قسم التسويق</p><p>الرياض</p><p>تلفون: &nbsp;966112650111+</p><p>البريد الإلكتروني: marketing@riyadhpharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            01/2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                  Rialocaine Gel 2%
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Lidocaine 2% w/w
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gel for topical and rectal administration.
Homogenous clear, colorless gel free from foreign particles

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>(Adults (&gt;18 years of age</p><p>Rialocaine Gel 2% (lidocaine hydrochloride) is indicated for</p><p>Surface anesthesia and lubrication for</p><ul><li>The male and female urethra during cystoscopy, catheterization, exploration by sound and other endourethral operations</li><li>Nasal and pharyngeal cavities in endoscopic procedures such as gastroscopy and bronchoscopy</li><li>Proctoscopy and rectoscopy</li><li>Tracheal intubation</li></ul><p>Symptomatic treatment of pain in connection with cystitis and urethritis</p><p><strong>(Geriatrics (&gt; 65 years of age</strong></p><p>Elderly patients should be given reduced doses commensurate with their age and physical condition</p><p><strong>(Pediatrics (&lt;18 years of age</strong></p><p>Children should be given reduced doses commensurate with their age, weight and physical condition). Lidocaine should be used with caution in children younger than two years of age as there are insufficient data to support the safety and efficacy of this product in this patient population at this time</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Dosing Considerations</strong></p><p><strong>General</strong></p><p>When Rialocaine Gel 2% ( lidocaine hydrochloride ) is used concomitantly with other products containing lidocaine, the total dose contributed by all formulations must be kept in mind</p><p>The absorption of lidocaine gel from the nasopharynx is usually lower than with other lidocaine products. Blood concentrations of lidocaine after instillation of the gel in the intact urethra and bladder in doses up to 800 mg are fairly low and below toxic levels</p><p><strong>Special Populations</strong></p><p>Lidocaine should also be used with caution in patients with epilepsy, impaired cardiac conduction, bradycardia, impaired hepatic or renal function and in severe shock</p><p>Debilitated patients, elderly patients, acutely ill patients, patients with sepsis, and children should be given reduced doses commensurate with their age, weight and physical condition</p><p>Rialocaine Gel 2% should be used with caution in children under the age of &nbsp;2 as there is insufficient data to support the safety and efficacy of this product in this patient population at this time</p><p><strong>Recommended Dose and Dosage Adjustment</strong></p><p><strong>Urethral Anesthesia</strong></p><p><u>Surface Anesthesia of the Male Adult Urethra</u></p><p>For adequate analgesia in males, 20 mL (400 mg lidocaine hydrochloride) gel is usually required. The gel is instilled slowly until the patient has a feeling of tension (approximately 10 mL) (200 mg). A penile clamp is then applied for several minutes at the corona, after which the rest of the gel is instilled</p><p>When anesthesia is especially important, e.g., during sounding or cystoscopy, a larger quantity of gel (e.g., 30-40 mL) may be instilled in 3-4 portions and allowed to act for 10-12 minutes before insertion of the instrument. The gel instilled into the bladder is also effective for procedures in this region</p><p>To anesthetize only the anterior male urethra, e.g., for catheterization, small volumes (5-10 mL, i.e., 100-200 mg lidocaine HCl) are usually adequate for lubrication</p><p><u>For Surface Anesthesia of the Female Adult Urethra </u></p><p>Instill 5-10 mL of gel in small portions to fill the whole urethra. If desired, some gel may be deposited on the orifice and covered with a cotton swab. In order to obtain adequate anesthesia, several minutes should be allowed prior to performing urological procedures</p><p><strong>Endoscopy</strong></p><p>The instillation of 10-20 mL is recommended for adequate analgesia and a small amount may be applied to the lubricating instrument. When combined with other lidocaine products (e.g., for bronchoscopy), the total dose of lidocaine should not exceed 400 mg</p><p><strong>Proctoscopy and rectoscopy</strong></p><p>Up to 20 mL can be used for anal and rectal procedures. The total dose should not exceed 400 mg lidocaine</p><p><strong>Lubrication for Endotracheal Intubation</strong></p><p>Apply approximately 2 mL of gel to the external surface of the endotracheal tube just prior to insertion. Care should be taken to avoid introducing the product into the lumen of the tube</p><p>Do not use the gel to lubricate endotracheal stylettes. It is also recommended that the use of endotracheal tubes with dried gel on the external surface be avoided for lack of lubricating effect</p><p><strong>Maximum Dosage</strong></p><p><u>Adults</u></p><p>The dose of Rialocaine Gel 2% depends on the application site. A safe dose for oral use is 400 mg (20 mL). A safe dose for use in the urethra and bladder is 800 mg (40 mL). A maximum single dosage for Rialocaine Gel 2% is not established. No more than four doses should be given during a 24-hour period</p><p><u>(Children (Under 12 Years</u></p><p>It is difficult to recommend a maximum dose of any drug for children since this varies as a function of age and weight. The maximum amount per dose of Rialocaine Gel 2% should not exceed 6 mg/kg of body weight or 3 mL per 10 kg weight. No more than four doses should be given during a 24-hour period</p><p>For children over 12 years of age doses should be commensurate with weight and physical condition</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components in the formulation 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>General</strong></p><p>excessive dosage, or short &nbsp;intervals between doses, can result in high plasma levels of lidocaine or its metabolites and serious adverse effects. Absorption from the mucous membranes is variable but is especially high from the bronchial tree. Such applications may therefore result in rapidly rising or excessive plasma concentrations, with an increased risk for toxic symptoms, such as convulsions. PATIENTS SHOULD BE INSTRUCTED TO STRICTLY ADHERE TO THE RECOMMENDED DOSAGE. This is especially important in children where doses vary with weight. The management of serious adverse reactions may require the use of resuscitative equipment, oxygen and other resuscitative drugs</p><p>The lowest dosage that results in effective anesthesia should be used to avoid high plasma levels and serious adverse effects. Tolerance to elevated blood levels varies with the status of the patient</p><p>Lidocaine should be used with caution in patients with sepsis and/or traumatized mucosa at the area of application, since under such conditions there is the potential for rapid systemic absorption</p><p>Rialocaine Gel 2% should be used with caution in children under the age of 2 as there is insufficient data to support the safety and efficacy of this product in this patient population at this time</p><p>In patients under general anesthesia who are paralyzed, higher plasma concentrations may occur than in spontaneously breathing patients. Unparalyzed patients are more likely to swallow a large proportion of the dose, which then undergoes considerable first-pass hepatic metabolism following absorption from the gut</p><p>Avoid contact with eyes</p><p>Many drugs used during the conduct of anesthesia are considered potential triggering agents for familial malignant hyperthermia. It has been shown that the use of amide local anesthetics in malignant hyperthermia patients is safe However, there is no guarantee that neural blockade will prevent the development of malignant hyperthermia during surgery. It is also difficult to predict the need for supplemental general anesthesia. Therefore, a standard</p><p>protocol for the management of malignant hyperthermia should be available</p><p>When used for endotracheal tube lubrication, care should be taken to avoid introduction of the Gel into the lumen of the tube. If allowed into the inner lumen, the gel may dry on the inner surface leaving a residue which tends to clump with flexion, narrowing the lumen. There have been rare reports in which this residue has caused the lumen to occlude. Similarly, do not use the Gel to lubricate the endotracheal stylettes</p><p>When topical anesthetics are used in the mouth, the patient should be aware that the production of topical anesthesia may impair swallowing and thus enhance the danger of aspiration. Numbness of the tongue or buccal mucosa may enhance the danger of unintentional biting trauma. Food or chewing gum should not be taken while the mouth or throat area is anesthetized</p><p>Rialocaine Gel 2% is ineffective when applied to intact skin</p><p>Lidocaine has been shown to be porphyrinogenic in animal models</p><p>Rialocaine Gel 2% should only be prescribed to patients with acute porphyria on strong or urgent indications,</p><p>when they can be closely monitored. Appropriate precautions should be taken for all porphyric patients</p><p>&nbsp;</p><p><strong>Cardiovascular</strong></p><p>Lidocaine should be used with caution in patients with bradycardia or impaired cardiovascular function since they may be less able to compensate for functional changes associated with the prolongation of A-V conduction produced by amid-type local anesthetics</p><p>Lidocaine should be used with caution in patients in severe shock</p><p>&nbsp;</p><p><strong>Hepatic</strong></p><p>Because amide-type local anesthetics such as lidocaine are metabolized by the liver, these drugs, especially repeated doses, should be used cautiously in patients with hepatic disease</p><p>Patients with severe hepatic disease, because of their inability to metabolize local anesthetics normally, are at greater risk of developing toxic plasma concentrations</p><p>&nbsp;</p><p><strong>Neurologic</strong></p><p><strong>Epilepsy: </strong>The risk of central nervous system side effects when using lidocaine in patients with epilepsy is very low, provided that the dose recommendations are followed</p><p><strong>Locomotion and Coordination: </strong>Topical lidocaine formulations generally result in low plasma concentrations because of a low degree of systemic absorption. However, depending on the dose, local anesthetics may have a very mild effect on mental function and coordination even in the absence of overt CNS toxicity and may temporarily impair locomotion and alertness</p><p>&nbsp;</p><p><strong>Renal</strong></p><p>Lidocaine is metabolized primarily by the liver to monoethylglycinexylidine (MEGX, which has some CNS activity), and then further to metabolites glycinexylidine (GX) and 2,6-dimethylaniline. Only a small fraction</p><p>(2%) of lidocaine is excreted unchanged in the urine. The pharmacokinetics of lidocaine and its main metabolite were not altered significantly in haemodialysis patients (n=4) who received an intravenous dose of lidocaine. Therefore, renal impairment is not expected to significantly affect the pharmacokinetics of lidocaine when Lidocaine Gel 2% is used for short treatment durations, according to dosage instructions</p><p>Caution is recommended when lidocaine is used in patients with severely impaired renal function because lidocaine metabolites may accumulate during long term treatment</p><p>&nbsp;</p><p><strong>Sensitivity</strong></p><p>Lidocaine should be used with caution in persons with known drug sensitivities</p><p>Lidocaine Gel 2% is contraindicated in patients with known hypersensitivities to local anesthetics of the amide type,or to other components in the formulation</p><p>&nbsp;</p><p><strong>Special Populations</strong></p><p>Debilitated patients, acutely ill patients, and patients with sepsis should be given reduced doses commensurate with their age, weight and physical condition because they may be more sensitive to systemic effects due to increased blood levels of lidocaine following repeated doses</p><p>&nbsp;</p><p><strong>Carcinogenesis and Mutagenesis</strong></p><p>Genotoxicity tests with lidocaine showed no evidence of mutagenic potential. A metabolite of lidocaine, 2,6-dimethylaniline, showed weak evidence of activity in some genotoxicity tests</p><p>A chronic oral toxicity study of the metabolite 2,6-dimethylaniline (0, 14, 45, 135 mg/kg) administered in feed to rats showed that there was a significantly greater incidence of nasal cavity tumors in male and female animals that had daily oral exposure to the highest dose of 2,6-dimethylaniline for 2 years. The lowest tumor-inducing dose tested in animals (135mg/kg) corresponds to approximately 50 times the amount of 2,6-dimethylaniline to which a</p><p>50 kg subject would be exposed following the application of 20 g of lidocaine gel 2% for 24 hours on the mucosa, assuming the highest theoretical extent of absorption of 100% and 80% conversion to 2,6-dimethylaniline. Based on a yearly exposure (once daily dosing with 2,6-dimethylaniline in animals and 5 treatment sessions with 20 g lidocaine gel 2% in humans), the safety margins would be approximately 3400 times when comparing the exposure in animals to man</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Drug-Drug Interactions</strong></p><p>Local anesthetics and agents structurally related to amide-type local anesthetics</p><p>Lidocaine should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics (e.g. antiarrhythmics such as mexiletine), since the toxic effects are additive</p><p><u>Antiarryhythmic Drugs</u></p><p><em>Class I Antiarrhythmic drugs</em></p><p>Class I antiarrhythmic drugs (such as mexiletine) should be used with caution since toxic effects are additive and potentially synergistic</p><p><em>Class III Antiarrhythmic drugs</em></p><p>Caution is advised when using Class III antiarrhythmic drugs concomitantly with lidocaine due to potential pharmacodynamic or pharmacokinetic interactions with lidocaine, or both. A drug interaction study has shown that the plasma concentration of lidocaine may be increased following administration of a therapeutic dose of intravenous lidocaine to patients treated with amiodarone (n=6). Case reports have described toxicity in patients treated concomitantly with lidocaine and amiodarone. Patients treated with Class III antiarrhythmic drugs (e.g.</p><p>amiodarone) should be kept under close surveillance and ECG monitoring should be considered, since cardiac effects of these drugs and lidocaine may be additive</p><p><u>Strong Inhibitors of CYP1A2 and CYP3A4</u></p><p>Cytochrome CYP1A2 and CYP3A4 are involved in the formation of the pharmacologically active lidocaine metabolite MEGX</p><p><em>Fluvoxamine: </em>Strong inhibitors of CYP1A2, such as fluvoxamine, given during prolonged administration of lidocaine to areas with a high extent of systemic absorption (e.g., mucous membranes) can cause a metabolic interaction leading to an increased lidocaine plasma concentration. The plasma clearance of a single intravenous dose of lidocaine was reduced by 41 to 60% during co-administration of fluvoxamine, a selective and potent CYP1A2 inhibitor, to healthy volunteers</p><p><em>Erythromycin and Itraconazole: </em>Erythromycin and itraconazole, which are strong inhibitors of CYP3A4, have been shown to reduce clearance of lidocaine by 9 to 18%, following a single intravenous dose of lidocaine to healthy volunteers</p><p>During combined co-administration with fluvoxamine and erythromycin the plasma clearance of lidocaine was reduced by 53%</p><p><u>&beta;-blockers and cimetidine</u></p><p>Following a single intravenous dose of lidocaine, administered to healthy volunteers, the clearance of lidocaine has been reported to be reduced up to 47% when co-administered with propanolol and up to 30% when co-administered with cimetidine. Reduced clearance of lidocaine when co-administered with these drugs is probably due to reduced liver blood flow and/or inhibition of microsomal liver enzymes. The potential for clinically significant</p><p>interactions with these drugs should be considered during long-term treatment with high doses of lidocaine</p><p><strong>Drug-Food Interactions</strong></p><p>Interactions of lidocaine with food have not been established</p><p><strong>Drug-Herb Interactions</strong></p><p>Interactions of lidocaine with herbal products have not been established</p><p><strong>Drug-Laboratory Tests Interactions</strong></p><p>Interactions of lidocaine with laboratory tests have not been established</p><p><strong>Drug-Lifestyle Interactions</strong></p><p>Interactions of lidocaine with lifestyle have not been established</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In common with other drugs, Lidocaine gel should not be used in early pregnancy unless the benefits outweigh the potential risks</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No or negligible influence. Lidocaine administered parenterally may cause CNS stimulation, dizziness, nausea followed by depression and drowsiness</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse experiences following the administration of lidocaine are similar in nature to those observed with other amide local anesthetic agents. These adverse experiences are, in general, dose-related and may result from high plasma levels caused by overdosage or rapid absorption, or may result from a hypersensitivity, idiosyncrasy or diminished tolerance on the part of the patient</p><p>An increased incidence of postoperative sore throat has been reported following endotracheal tube lubrication with lidocaine gel</p><p>Serious adverse experiences are generally systemic in nature. The following types are those most commonly reported</p><p><strong>Central Nervous System: </strong>CNS manifestations are excitatory and/or depressant and may be characterized by the following signs and symptoms of escalating severity: circumoral paresthesia, light-headedness, nervousness, apprehension, euphoria, confusion, dizziness, drowsiness, hyperacusis, tinnitus, blurred vision, vomiting, sensations of heat, cold or numbness, twitching, tremors, convulsions, unconsciousness, respiratory depression and arrest. The excitatory manifestations (e.g., twitching, tremors, convulsions) may be very brief or may not occur at all, in which case the first manifestation of toxicity may be drowsiness merging into unconsciousness and respiratory arrest.</p><p>Drowsiness following the administration of lidocaine is usually an early sign of a high lidocaine plasma level and may occur as a consequence of rapid absorption</p><p><strong>Cardiovascular System: </strong>Cardiovascular manifestations are usually depressant and are characterized by bradycardia, hypotension, arrhythmia and cardiovascular collapse, which may lead to cardiac arrest</p><p><strong>Allergic: </strong>Allergic reactions are characterized by cutaneous lesions, urticaria, edema or, in the most severe instances, anaphylactic shock. Allergic reactions of the amide type are rare (&lt;0.1%) and may occur as a result of sensitivity either to the local anesthetic agent or to other components in the formulation</p><p><strong><u>Reporting of suspected adverse reactions</u>&nbsp;</strong></p><p>- National Pharmacovigilance and Drug Safety Center (NPC)</p><ul><li>o Fax: +966-11-205-7662</li><li>o To contact national Pharmacovigilance management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340</li><li>o Toll-free: 8002490000</li><li>o E-mail: npc.drug@sfda.gov.sa</li><li>o Website: www.sfda.gov.sa/npc</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Acute systemic toxicity from local anesthetics is generally related to high plasma levels encountered during therapeutic use of local anesthetics and originates mainly in the central nervous and the cardiovascular systems</p><p>It should be kept in mind that clinically relevant pharmacodynamics drug interactions (i.e., toxic effects) may occur with lidocaine and other local anesthetics or structurally related drugs, and Class I and Class III antiarrhythimic drugs due to additive effects</p><p><strong>Symptoms</strong></p><p><em>Central nervous system </em>toxicity is a graded response, with symptoms and signs of escalating severity. The first symptoms are circumoral paresthesia, numbness of the tongue, lightheadedness, hyperacusis and tinnitus. Visual disturbance and muscular tremors are more serious and precede the onset of generalized convulsions</p><p>Unconsciousness and grand mal convulsions may follow, which may last from a few seconds to several minutes. Hypoxia and hypercarbia occur rapidly following convulsions due to the increased muscular activity, together with the interference with normal respiration. In severe cases apnea may occur</p><p>Acidosis, hyperkalaemia, hypocalcaemia and hypoxia increase and extend the toxic effects of local anesthetics.</p><p>Recovery is due to redistribution and metabolism of the local anesthetic drug. Recovery may be rapid unless large amounts of the drug have been administered</p><p><em>Cardiovascular </em>effects may be seen in cases with high systemic concentrations. Severe hypotension, bradycardia, arrhythmia and cardiovascular collapse may be the result in such cases</p><p>Cardiovascular toxic effects are generally preceded by signs of toxicity in the central nervous system, unless the patient is receiving a general anesthetic or is heavily sedated with drugs such as a benzodiazepine or barbiturate</p><p><strong>Treatment</strong></p><p>The first consideration is prevention, best accomplished by careful and constant monitoring of cardiovascular and respiratory vital signs and the patient&#39;s state of consciousness after each local anesthetic administration. At the first sign of change, oxygen should be administered</p><p>The first step in the management of systemic toxic reactions consists of immediate attention to the maintenance of a patent airway and assisted or controlled ventilation with oxygen and a delivery system capable of permitting immediate positive airway pressure by mask. This may prevent convulsions if they have not already occurred</p><p>If convulsions occur, the objective of the treatment is to maintain ventilation and oxygenation and support circulation. Oxygen must be given and ventilation assisted if necessary (mask and bag or tracheal intubation) Should convulsions not stop spontaneously after 15-20 seconds, an anticonvulsant should be given iv to facilitate adequate ventilation and oxygenation. Thiopental sodium 1-3 mg/kg iv is the first choice. Alternatively diazepam 0.1 mg/kg bw iv may be used, although its action will be slow. Prolonged convulsions may jeopardise the patient&#39;s ventilation and oxygenation. If so, injection of a muscle relaxant (e.g.succinylcholine 1 mg/kg bw) will facilitate ventilation, and oxygenation can be controlled</p><p>Early endotracheal intubation is required when succinylcholine is used to control motor seizure activity</p><p>If cardiovascular depression is evident (hypotension, bradycardia), ephedrine 5-10 mg i.v. should be given and may be repeated, if necessary, after 2-3 minutes</p><p>Should circulatory arrest occur, immediate cardiopulmonary resuscitation should be instituted</p><p>Continual oxygenation and ventilation and circulatory support as well as treatment of acidosis are of vital importance, since hypoxia and acidosis will increase the systemic toxicity of local anesthetics. Epinephrine (0.1-0.2 mg as intravenous or intracardial injections) should be given as soon as possible and repeated, if necessary</p><p>Children should be given doses of epinephrine commensurate with their age and weight</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Anaesthetics Local. Amides. ATC code: NO1BB</p><p>Lidocaine is an amide local anaesthetic agent with a fast onset, blocking peripheral nervous conduction</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption: </strong>The rate and extent of absorption depends upon concentration and total dose administered, the specific site of application and duration of exposure. In general, the rate of absorption of local anesthetic agents following topical application to wound surfaces and mucous membranes is high, and occurs most rapidly after intratracheal and bronchial administration. The absorption of &nbsp;lidocaine gel from the nasopharynx is usually lower than with other lidocaine products. Blood concentrations of lidocaine after instillation of the gel in the intact urethra and bladder in doses up to 800 mg are fairly low and below toxic levels</p><p>Lidocaine is also well absorbed from the gastrointestinal tract, although little intact drug may appear in the circulation because of biotransformation in the liver</p><p><strong>Distribution: </strong>Lidocaine has a total plasma clearance of 0.95 L/min and a volume of distribution at steady state of 91 L</p><p>Lidocaine readily crosses the placenta, and equilibrium in regard to free, unbound drug will be reached. Because the degree of plasma protein binding in the fetus is less than in the mother, the total plasma concentration will be greater in the mother, but the free concentrations will be the same</p><p>The plasma binding of lidocaine is dependent on drug concentration, and the fraction bound decreases with increasing concentration. At concentrations of 1 to 4 &mu;g of free base per mL,60 to 80 percent of lidocaine is protein bound. Binding is also dependent on the plasma concentration of the alpha-1-acid glycoprotein. Lidocaine crosses the blood-brain and placental barriers, presumably by passive diffusion</p><p><strong>Metabolism: </strong>Lidocaine is metabolized rapidly by the liver, and its metabolites and the unchanged drug are excreted by the kidneys. Biotransformation includes oxidative Ndealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation. Only 2% of lidocaine is excreted unchanged. Most of it is metabolized first to monoethylglycinexylidide (MEGX) and then to glycinexylidide (GX) and 2,6-dimethylaniline. Up to 70% appears in the urine as 4-hydroxy- 2,6-dimethylaniline. The pharmacological/toxicological actions of MEGX and GX are similar to, but less potent than those of lidocaine. GX has a longer half-life (about10 h) than lidocaine and may accumulate during long-term administration</p><p><strong>Excretion: </strong>Lidocaine has an elimination half-life of 1.6 h and an estimated hepatic extraction ratio of 0.65. The clearance of lidocaine is almost entirely due to liver metabolism, and depends both on liver blood flow and the activity of metabolizing enzymes. Approximately 90% of the lidocaine administrated intravenously is excreted in the form of various metabolites, and less than 10% is excreted unchanged in the urine. The primary metabolite in</p><p>urine is a conjugate of 4-hydroxy- 2,6-dimethylaniline, accounting for about 70-80% of the dose excreted in the urine</p><p>The elimination half-life of lidocaine following an intravenous bolus injection is typically 1.5 to 2.0 hours. The elimination half-life in neonates (3.2 h) is approximately twice that of adults. The half-life may be prolonged two-fold or more in patients with liver dysfunction</p><p>Renal dysfunction does not affect lidocaine kinetics but may increase the accumulation of</p><p>metabolites</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glycerol</p><p>Hypromellose</p><p>Methyl hydroxybenzoate</p><p>Propyl hydroxybenzoate</p><p>Water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None Known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 Years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg; C</p><p>Keep in the original container to protect from light</p><p>Once the pack has been opened , the content should be used within one month</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Aluminium Tube with plastic screw cap</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Apply using gauze or barrier gloves, if not available - wash hands after application</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O.Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation holder
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                10/2017 
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>